Alzheimer's Disease Education and Referral Center

Search for Alzheimer's Clinical Trials


Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION)


Study Overview

Record IDs:

 ADEAR: IA0188, NLM: NCT00948766

Current Status:

 No longer recruiting

Purpose:
This study will assess the efficacy of a higher dose of rivastigmine patch (15 cm2) compared to a lower dose of the rivastigmine patch (5 cm2), in patients with severe dementia of the Alzheimer's type.

Sponsor(s):

 Novartis

Official Title:

 A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).

Principal Investigator(s):

 Novartis Pharmaceuticals , 

Start Date:

 July 2009

Anticipated End Date:

April 2012

Expected Enrollment:

 712


Qualifications for this Study

Minimum Age Maximum Age Gender Accepts Healthy Volunteers? Disease Stage Inpatient/Outpatient
50 None Both No Late
 Outpatient


Inclusion Criteria:

    * Diagnosis of probable Alzheimer's disease (AD) according to National Institute of Neurological Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) criteria
    * Mini Mental State Examination (MMSE) score of ≥ 3 and ≤ 12
    * Able to complete at least one item on the Severe Impairment Battery (SIB)
    * Residing with someone in the community or in regular contact with the primary caregiver
    * Ambulatory or ambulatory with aid


Exclusion Criteria:

    * Advanced, severe, progressive, or unstable disease of any type that may interfere with efficacy and safety assessments or put the patient at special risk
    * Patients currently residing in a nursing home
    * Any current medical or neurological condition other than AD that could explain the patient's dementia
    * Current diagnosis of probable or possible vascular dementia
    * Current diagnosis of severe or unstable cardiovascular disease
    * Current diagnosis of bradycardia (< 50 bpm), sick-sinus syndrome, or conduction defects
    * Clinically significant urinary obstruction
    * History of malignancy of any organ system within the past 5 years unless patient is verified to be in stable condition with no active metastasis
    * Current diagnosis of an active skin lesion/disorder that would prevent the patient from using a transdermal patch every day
    * Known exaggerated pharmacological sensitivity or hypersensitivity to drugs similar to rivastigmine, or to other cholinergic compounds

    Other protocol-defined inclusion/exclusion criteria may apply


Prohibited Medications:

    taken any of the following substances (At the time of the Baseline Visit (Visit 2))
    * Succinylcholine-type muscle relaxants during the 2 weeks prior to baseline
    * Lithium during the 2 weeks prior to baseline
    * Investigational drug during the 4 weeks prior to baseline
    * A drug or treatment known to cause major organ system toxicity during the 4 weeks prior to baseline
    * Rivastigmine (oral or transdermal patch), donepezil, galantamine, other cholinesterase inhibitors (e.g., tacrine, physostigmine, or pyridostigmine), other approved treatments for Alzheimer's disease during the 2 weeks prior to baseline
    with exception of stable treatment with memantine for at least 3 months before study entry (Visit 1)
    * Centrally acting anticholinergic drugs including tricyclic and tetracyclic antidepressants during the 4 weeks prior to baseline
    * Selegiline unless taken at a stable dose during the 4 weeks prior to baseline
    * Peripheral anticholinergics not taken at a stable dose during the 4 weeks prior to baseline



Study Description



Phase 4, Treatment, Randomized, Double Blind , Active, Parallel, Safety/Efficacy  Study

Intervention Type Name Manufacturer Classification
Drug rivastigmine transdermal patch (Exelon Patch) Novartis cholinesterase inhibitors


 

Study Contact

Name:

 Novartis Pharmaceuticals 

Telephone:

 862-778-8300

Email:


All U.S. Trial Sites:

State City Zip Code Location Contact
ArizonaGilbert,85234Clinical Research Advantage/Neuro. Physicians of Arizona, Inc
 
480-610-0177
ArizonaTucson86741 Northwest Neuro Specialist
 
520-742-1833
ArkansasConway 72034 IHS Research Center Incorporated
 
501-247-6439
CaliforniaBerkeley94705The Research & Education Inst. of Alta Bates Summit Med. Group
 
510-849-0417
CaliforniaCosta Mesa92626 ATP Clinical Research, Inc
 
714-277-4472
CaliforniaFresno93710 Margolin Brain Institute
 
559-299-1515
CaliforniaGarden Grove92845Collaborative Neuroscience Network
 
714-799-7799
CaliforniaLa Habra90631 Neurology Center of N.Orange County
 
714-879-7200
CaliforniaLos Angeles90033 University of Southern California-School of Medicine
 
323-442-7594
CaliforniaOceanside92056 The Neurology Center
 
760-732-0557
CaliforniaPoway92064 The Center for Memory and Aging
 
858-674-1289
CaliforniaRedlands92374 Anderson Clinical Research
 
909-792-9007
CaliforniaSan Francisco94109 San Francisco Clinical Research Center
 
415-673-4600
CaliforniaSanta Ana92701 Neuropsychiatric Research Center of Orange County
 
949-294-7599
CaliforniaSherman Oaks91403 California Neuroscience Research Medical Group, Inc
 
818-990-2671
CaliforniaTemecula92591 Viking Clinical Research Center
 
800-670-4960
CaliforniaTorrance,90502 CNS Network
 
ColoradoAurora80014Senior Care of Colorado
 
303-306-4357
FloridaBoca Raton33431 Florida Atlantic University
 
561-297-2185
FloridaDelray Beach33431 Brain Matters Research, Inc.
 
561-374-8461
FloridaFort Lauderdale33308 Neurologic Consultants, PA
 
954-776-9111
FloridaFort Walton Beach32547SJS Clinical Research
 
850-863-8169
FloridaHallandale Beach33009 MD Clinical
 
954-455-5757
FloridaHollywood33021Sunrise Clinical Research, Inc
 
954-981-3850
FloridaPensacola32514 Integrity Research, LLC
 
850-484-7556
FloridaPompano Beach33064 Quantum Lab. at N. Broward Memory Disorder Center
 
954-786-7331
FloridaPort Charlotte33952 Neurostudies, Inc.
 
941-764-0800
FloridaTampa33613 Stedman Clinical Trials
 
813-971-8311
FloridaVenice34285 Center for Clinical Trials, LLC
 
941-488-0124
FloridaWest Palm Beach33407 Premiere Research Institute
 
561-845-0500
IdahoIdaho Falls83404 Rocky Mountain Diabetes and Osteoporosis
 
208-528-9641
IllinoisElk Grove Village60007Alexian Brothers Neuroscience Institute
 
847-640-5605
IndianaElkhart46514 Elkhart Clinic, LLC
 
574-296-3286
IndianaIndianapolis46202Indiana University School of Medicine
 
317-274-9903
KansasKansas City66160 University of Kansas Medical Center
 
913-588-0685
KansasLenexa66214 MidAmerica Neuroscience Reseach Foundation
 
913-894-1500
KansasManhattan66502 Precise Clinical Research
 
785-217-6559
LouisianaNew Orleans70115 LSU Health Sciences Center/LSU School of Medicine
 
318-813-2072
LouisianaShreveport71104J. Gary Booker, MD APMC
 
318-227-9600
MarylandBaltimore21208 Pharmasite Research
 
410-602-0555
MarylandBaltimore 21224 John Hopkins Bayview Hospital
 
410-550-9054
MarylandEaston 21601 Shore Psychiatric Associates
 
410-820-4005
MarylandGlen Burnie 21061 Clinical Insights
 
410-768-2629
MarylandSalisbury21801 Delmarva Family Resources
 
410-334-6687
MassachusettsJamaica Plain02130 VA Boston Healthcare System
 
857-364-4812
MassachusettsPittsfield 01201 Neuroscience Research of the Berkshires
 
413-499-7128
MichiganClinton Township48035 Michigan Neurology Associates, P.C.
 
586-464-2026
MichiganMuskegon 49442 West Michigan Clinical Research
 
231-727-4369
MinnesotaSt. Paul55114Orr & Associates Memory and Geriatric Behavioral Health Clinic
 
612-281-5314
MississippiOcean Springs39564Gulf Coast Neurology Center
 
228-818-9620
MissouriSt. Louis63104 St. Louis University Hospital
 
314-977-4820
MissouriSt. Louis63117 St. Mary's Health Center
 
314-647-4488
MontanaMissoula59802 Montana Neuroscience Institute Foundation
 
406-329-2617
NebraskaOmaha68105U of Nebraska Medical Center
 
402-552-6005
New JerseyEatontown07724 Memory Enhancement Center of America, Inc.
 
732-263-0101
New JerseyManchester08759 Meridian Institute Aging/Alzheimer's Research Corp
 
732-657-6100
New JerseyNew Brunswick08903 UMDNJ-Robert Wood Johnson Medical Center
 
732-418-8468
New JerseySomerset08873 Princeton and Rutgers Neurology
 
732-246-1311
New JerseyStratford08084UMDNJ-School of Osteopathic Medicine Center
 
856-566-6843
New YorkAlbany12205 Upstate Clinical Reserach, LLC
 
518-533-1546
New YorkAmherst14226 Dent Neurological Institute
 
716-250-2008
New YorkLatham,Neurological Research Center
 
518-785-1000
New YorkStaten Island 10305 Behavioral Medical Research of Staten Island
 
718-351-1806
New YorkStaten Island10312 Richmond Behavioral Associates
 
718-227-1897
New YorkSyracuse13210 Neurological Care of Central NY
 
315-701-4554
New YorkWhite Plains10605 Burke Medical Research Institute
 
914-597-2476
North CarolinaDurham27705 Duke University - Dept of Neurology
 
919-668-1538
North CarolinaWinston Salem27103 Clinical Trials of America
 
336-768-3456
OhioCenterville45459Valley Medical Center
 
937-208-8298
OhioCincinnati45267 University of Cincinnati
 
513-475-8781
OregonPortland97225Providence Brain Institute Cognitive Assessment Clinic
 
503-216-2736
PennsylvaniaAllentown18104Lehigh Center for Clinical Research
 
610-820-0342
PennsylvaniaBeaver15009 Tri-State Medical Group
 
724-774-7743
PennsylvaniaCoatesville19320Coatesville VA Medical Center
 
610-384-7711 ext.5729
PennsylvaniaGreensburg15601Westmoreland Neurology
 
724-836-1921
PennsylvaniaPhiladelphia19107 Thomas Jefferson University, Dept. of Phsyciatry & Neurology
 
215-503-1243
Rhode IslandEast Providence02914 Rhode Island Mood & Memory Research Institute
 
401-435-8950
TennesseeNashville37208 Meharry Medical College
 
615-327-6884
TexasBaytown77521Jacinto Medical Group
 
281-425-3840
TexasDallas75231 FutureSearch Trials
 
214-369-2600
TexasGalveston 77555 University of Texas Medical Branch
 
409-772-8068
TexasSan Antonio78229 Innovative Clinical Trials, Bexar Diagnostic Medicine Assoc
 
210-377-2873
TexasSan Antonio78229 Radiant Research - San Antonio
 
210-614-7483
VirginiaArlington22205Integra Trials Llc
 
703-528-0385
VirginiaRichmond23226 Neorological Associates
 
804-288-2742
VirginiaRichmond 23230 Alliance Research Group, LLC
 
804-353-4494
VirginiaWilliamsburg 23185 The Center for Excellence in Aging and Geriatric Health
 
757-220-4751
WashingtonSeattle98144 Pacific Medical Centers
 
206-621-4391
WashingtonSeattle98108 Veterans Affairs Puget Sound Health Care System
 
206-764-2339
WashingtonTacoma98405Internal Medicine Northwest
 
253-882-1081
WisconsinWaukesha53188Independent Psychiatric Consultants, SC
 
262-513-0700


Trial Sites Outside U.S.:

Country State City Zip Code Location Contact
Puerto Rico Bayamon 00959 Caribbean Education and Research Center
  
+1 787 786 0575
Puerto Rico San Juan, 00918 INSPIRA Clinical Research
  

 

Links:


Back to Search